21GRAMS and Havas Lynx lead the charge at the PM Society Awards for pharma marketing and healthcare communications.
From prostate cancer to hormonal health, many areas of men’s health require more attention. As male life expectancy and healthy lifespan continue to lag behind, Charlie Bryant at Androlabs explores how pharma could help improve this by shifting its focus from treatment to prevention.
Dr Werner Engelbrecht at Veeva Systems discusses how compliance can be turned into a competitive advantage with connected platforms and data, efficiencies from AI and new patient-centric models.
Tina Backhouse from Theramex looks at daunting treatment access challenges women face.
From the role of the media to the types of daily struggles people face, Pharmafocus presents some of the key issues ahead of this year’s Mental Health Awareness Week.
Page 4 – Galapagos confirms new leadership changes as the planned of the company split nears.
Page 6 – Novo Nordisk’s Rybelsus found to reduce major adverse cardiovascular events.
Page 8 – Sanofi’s chlamydia vaccine put on FDA fast track.
Page 10 – Cold Chain Technologies acquires Global Cold Chain Solutions.
Page 12 – ProBioGen promotes Alfred Merz to chief executive officer.
Executive Director
PMGroup Worldwide Ltd
Karl Equi
Group Managing Editor
Iona Everson
Editors
James Spargo
james@samedanltd.com
Deputy Editor
Emily Kimber
ekimber@pmlive.com
News Journalist
Ella Day
ella@samedanltd.com
Business Manager
Louise Wilson-English
louise@samedanltd.com
Design & Layout
Peter May
Pharmafocus is published by:
Samedan Ltd
44 Maiden Lane, London
WC2E 7LN
Tel: +44 (0)20 7724 3456
Fax: +44 (0)20 7403 7747
Subscriptions & Data Management
Curwood CMS Tel: 01580 883840
ISSN: 1465-5403
Pharmafocus is sent free of charge to selected permanent employees of ethical and OTC pharmaceutical and biotech companies. Employees are specifiers from middle and senior management with responsibility for making buying decisions. Selection is at the discretion of the Publisher. Copies are also available on a subscription basis at an annual fee of £115 (UK), £145 (Europe) and £185 (RoW).
All subscriptions payable to Samedan. Back copies can be purchased for £15.00 each. Pharmafocus is published by Samedan Ltd. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form without permission, unless for the purposes of reference and comment.
©2025 Samedan Ltd, Pharmaceutical Publishers
The opinions and views expressed by contributors to this publication are not necessarily those of the Editor or the Publisher and, while every care has been taken in the preparation of the newspaper, the Editor and the Publisher are not responsible for such opinions and views, or for any inaccuracies in the articles. The Publisher is not responsible for any images supplied by contributors. While every care is taken with artwork supplied, the Publisher cannot be held responsible for any loss or damage incurred. The entire content of this publication is protected by copyright. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form, by any means – electronic, mechanical, photocopying or otherwise – without the prior permission of the Publisher.